The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011

Frank Lichtenberg

No 21239, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: The premature cancer mortality rate has been declining in Canada, but there has been considerable variation in the rate of decline across cancer sites. I analyze the effect that pharmaceutical innovation had on premature cancer mortality in Canada during the period 2000-2011, by investigating whether the cancer sites that experienced more pharmaceutical innovation had larger declines in the premature mortality rate, controlling for changes in the incidence rate. The estimates imply that pharmaceutical innovation during the period 1985-1996 reduced the number of years of potential life lost to cancer before age 75 in 2011 by 105,366. The cost per life-year before age 75 gained from previous pharmaceutical innovation is estimated to have been 2730 USD. The evidence suggests that, even if these drugs had been sold at branded rather than generic prices, the cost per life-year gained would have been below 11,000 USD, a figure well below even the lowest estimates of the value of a life-year gained.

JEL-codes: C23 C33 I10 J11 J17 L65 O33 (search for similar items in EconPapers)
Date: 2015-06
New Economics Papers: this item is included in nep-hea, nep-ino and nep-lma
Note: EH PR
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (7)

Published as International Journal of Health Economics and Management: Volume 15, Issue 3 (2015), Page 339-359
Published as Frank Lichtenberg, 2015. "The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000–2011," International Journal of Health Care Finance and Economics, Springer, vol. 15(3), pages 339-359, September.

Downloads: (external link)
http://www.nber.org/papers/w21239.pdf (application/pdf)

Related works:
Journal Article: The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000–2011 (2015)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:21239

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w21239

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().